Search Tag: CVD
2024 07 Feb
Findings of the World Heart Report 2023 offer a comprehensive overview of cardiovascular health dimensions, trends and the current landscape. Drawing from epidemiological, policy, and economic data, the report is a valuable resource for national and international policymakers in identifying and addressing critical cardiovascular health priorities....Read more
2024 30 Jan
Over half of the U.S. population (51%) remains unaware that heart disease is the leading cause of death, as per a recent Harris Poll survey conducted by the American Heart Association. This lack of awareness persists despite heart disease maintaining its status as the number one killer for over a century. Heart Disease and Stroke Statistics report...Read more
2023 29 Sep
Much has changed since the introduction of the charter sixteen years ago; Europe needs a new plan of action that goes beyond health considerations — one fit for 2023 and beyond. Cardiovascular disease (CVD) is the leading cause of death globally and costs the EU economy 282 billion euros per year. The European Heart Health Charter, launched...Read more
2023 26 Aug
New research presented at the ESC Congress 2023 reveals that cardiovascular disease (CVD) costs the European Union (EU) an estimated €282 billion in 2021. The analysis was a collaborative study by the European Society of Cardiology (ESC) and the University of Oxford, UK. This figure highlights the significant impact of CVD on the region. ...Read more
2023 19 Jul
Individuals facing difficulty finding time to exercise during a busy work week can still benefit from their physical activity by concentrating their moderate-to-vigorous exercise on one to two days of the week or the weekend. A recent study published in JAMA, conducted by investigators from Massachusetts General Hospital (MGH), explored...Read more
2023 27 Jun
A recent study conducted by researchers of the IDIBAPS Translational research in diabetes, lipids and obesity group and the University Oberta de Catalunya (UOC) shows that a higher level of carotenes in the bloodstream is associated with a reduced incidence of atherosclerosis in the arteries and a lower risk of cardiovascular diseases. The findings...Read more
2023 16 Mar
A new study published in the European Heart Journal provides the first evidence linking exceeding the World Health Organization's (WHO) ozone limit with a substantial increase in hospital admissions for heart attack, heart failure, and stroke. Ozone levels below the WHO maximum were also found to be associated with worsened health. This was a...Read more
2023 04 Mar
According to a team of researchers led by the University of Cambridge, managing at least half of the recommended level of physical activity could prevent one in ten early deaths. The study is published a study in the British Journal of Sports Medicine. It shows that just 11 minutes of moderate-intensity physical activity per day (75 minutes per...Read more
2022 19 Jul
An analysis of more than 6000 adults with a history of cardiovascular disease (CVD) showed that CVD risk profiles in secondary prevention have failed to improve over the last two decades. The findings are published in the Journal of the American College of Cardiology . Despite significant advancements in safe and effective therapies, the trends...Read more
2022 21 Jun
Cardiometabolic diseases, including type 2 diabetes, ischaemic heart disease, heart failure or atrial fibrillation and stroke, are some of the primary risk factors for dementia. A new study published in the journal Alzheimer's & Dementia shows that people with at least two of the diseases - type 2 diabetes, heart disease or stroke - have double the...Read more
2022 08 Feb
A new study shows clinical decision support system (CDSS) software use was associated with significantly improved reversible risk of cardiovascular disease among socioeconomically vulnerable, high-risk patients. The study of more than 18,000 patients at community health centers (CHCs) was published Feb. 4 in the Journal of the American Medical Association...Read more
2022 31 Jan
Cardiovascular diseases (CVDs) are the number one cause of death and disability globally. Hypertension is a leading risk factor for CVD and causes over 10 million deaths worldwide each year. Over the last 30 years, deaths and disability from cardiovascular disease have been steadily rising across the globe. In 2019 alone, the condition, which includes...Read more
2021 29 Jun
Cancer and cardiovascular disease are the two leading causes of mortality. They are also leading contributors to increasing healthcare costs for both healthcare systems and patients. Financial toxicity is a well-known side effect of the high costs associated with cancer care. However, in recent years, clinical studies have suggested that...Read more
2021 30 Mar
Cardiovascular disease continues to be a leading cause of death worldwide. There are several contributing factors to the development of cardiovascular disease. However, a poor diet is one of the most highlighted and most discussed factors. Poor diet is a modifiable risk factor for cardiovascular disease. Nearly 10 million deaths from cardiovascular...Read more
2020 28 Sep
On World Heart Day this year (29 September), the World Heart Federation (WHF) cautions heart patients to be aware of COVID-19 and its impact on the heart. According to the WHF, COVID-19 is creating a perfect storm for heart health. Three factors are contributing to this: 1. People with COVID-19 and heart disease are at the highest risk of death...Read more
2020 09 Jul
As the world continues to struggle through the COVID-19 pandemic, an area of concern is the increasing burden of cardiovascular disease. CVD was already an area of concern before the coronavirus outbreak since it is the leading cause of death in the world. However, the pandemic has made the outlook for CVD even more gloomy. Approximately 60...Read more
2020 25 Mar
The world is facing a health crisis. It all started with China but now, Europe accounts for about three quarters of new daily cases. Italy and Spain are in a very difficult situation, and France and Germany are not so far behind. The European Society of Cardiology (ESC) has recently put together a series of practical podcasts from speakers with the...Read more
2020 20 Feb
Despite significant advances in the diagnosis and management of cardiac disease, cardiovascular disease continues to have high morbidity and mortality. In some cases, the diagnosis is delayed, while in others, the diagnosis is mistaken for another disorder. Advanced technology and machine learning have opened up new opportunities to evaluate image-based...Read more
2019 16 Dec
A new paper in Family Practice, published by Oxford University Press, found that the widespread use of statins and cancer screening technology may have altered the benefits of aspirin use. Researchers concluded that aspirin no longer provides a net benefit as primary prevention for cardiovascular disease and cancer. Nearly half of adults 70 years...Read more
2019 16 Dec
Middle-income countries shoulder the bulk of morbidity and mortality from cardiovascular disease (CVD) in Europe, according to a major report published today in European Heart Journal. The document details the burden of CVD in the 57 ESC member countries, the infrastructure and human resources available for treatment, and the vast differences...Read more
2019 02 Oct
Despite underlying physiological differences and a different set of risk factors, diagnosis, management, and treatment strategies for hypertension do not account for sex and gender variances. Evidence-based guidelines for hypertension treatment from clinical trials are similar between males and females; however, most of these trials do not...Read more
2019 02 Oct
Summary: A presentation of a case study in light of the updated ESC guidelines on lipid control and new guidelines on diabetes and cardiovascular disease. Several new guidelines were released at the European Society of Cardiology (ESC) Congress in Paris, France. These included updated guidelines on lipid control and new guidelines...Read more
2019 23 Sep
A combination pill containing three medications used to tackle high blood pressure and one used for high cholesterol was found to reduce cardiovascular disease (CVD) risk by 25%. The study, published in the New England Journal of Medicine (NEJM), assessed the effectiveness of atorvastatin, amlodipine, losartan and hydrochlorothiazide in polypill...Read more
2019 26 Aug
Arthur M. Feldman, MD, PhD, Laura H. Carnell Professor of Medicine at the Lewis Katz School of Medicine at Temple University, has been recognised with the 2019 Distinguished Scientist Award-Basic Domain by the American College of Cardiology. Prof. Feldman has received this honour due to his contribution towards improving cardiovascular health and...Read more
2019 26 Aug
Summary: Overview about the value of mHealth in cardiology exemplified by some promising tools that for sure will change the way cardiology is practiced, especially in the management of rhythm disturbances like atrial fibrillation. Where Are We Now? Nowadays, there is a lot of hype about the role of wearables and mobile health (mHealth)...Read more
2019 26 Aug
Summary: Differences in sex and gender may account for gaps in treatment and prevention of cardiovascular disease, but at the same time, it also gives the opportunity for personalised sex and gender-specific medicine. Typical presentations in medicine are defined in ways that health care professionals can draw on past experiences and education...Read more
2019 26 Aug
Summary: Cardiovascular disease prevention strategies in 2019 remain a major healthcare issue, requiring an individualised approach for diagnostic and therapeutic decision making. Introduction Since investigators from the Framingham Heart Study first confirmed the existence and importance of cardiovascular disease (CVD) risk factors in...Read more
2019 26 Aug
Summary: Nuclear cardiology is a promising field located between research, imaging, and patient care. Through close interdisciplinary cooperation, a variety of cardiovascular diseases (eg coronary artery, inflammatory and infiltrative cardiac diseases) can not only be investigated, but also efficiently treated in daily clinical routine. What...Read more
2019 26 Aug
How can we get the most common, costly, and modifiable cardiovascular risk factor under control? Cardiovascular disease (CVD) is the number one cause of death with an upward trend beyond 30% and a tripling in costs between 2010 and 2030, placing a significant economic burden on public healthcare services. 1,2,3 The most common risk factor...Read more